Table III.
Preoperative predictive factors for microsatellite distance >1 cm on univariate and multivariate regression models.
| Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|
|
|
|
||||
| Parameters | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | AUC |
| Age (years) | 0.97 (0.91–1.13) | 0.273 | |||
| BMI (kg/m2) | 0.86 (0.65–1.07) | 0.251 | |||
| AST (IU/l) | 1.00 (0.98–1.03) | 0.501 | |||
| ALT (IU/l) | 0.99 (0.96–1.02) | 0.863 | |||
| PLT (x104/μl) | 1.07 (0.96–1.19) | 0.180 | |||
| TBil (mg/dl) | 0.26 (0.01–2.11) | 0.327 | |||
| Alb (g/dl) | 1.34 (0.35–6.40) | 0.819 | |||
| PT (%) | 1.00 (0.94–1.07) | 0.868 | |||
| AFP (ng/ml) | 1.00 (0.99–1.00) | 0.182 | |||
| PIVKA-II (mAU/ml) | 1.00 (0.99–1.00) | 0.122 | |||
| HbA1c (%) | 0.41 (0.09–1.34) | 0.182 | |||
| Diameter of tumor (cm) | 1.23 (1.04–1.39) | 0.017 | 1.06 (0.82–1.32) | 0.591 | |
| SUVmax | 1.65 (1.30–2.29) | 0.003 | 1.60 (1.23–2.26) | 0.002 | 0.854 |
CI, confidence interval; AUC, area under the receiver operating characteristic curve; BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; PLT, platelet count; TBil, total bilirubin; Alb, albumin; PT, prothrombin time; AFP, α-fetoprotein; PIVKA-II, protein induced by vitamin K absence or antagonist-II; HbA1c, hemoglobin A1c; SUVmax, maximal standardized uptake value.